ReviewBiomedicines2022

Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway.

Hanbyeol Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.